Methocarbamol Tablets Mislabeled with Incorrect Strength
Bryant Ranch Prepack is recalling Methocarbamol 500mg tablets nationwide because the bottles are mislabeled—they actually contain 750mg tablets. The affected lot was distributed in 30-, 60-, and 90-count bottles.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class I recall involving a prescription medication with a significant labeling error—the actual strength is 50% higher than the labeled strength. Incorrect dosing of a muscle relaxant could result in overdose, adverse effects, and potential hospitalization, meeting the Severe classification criteria.
Plain-English summary
Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals is recalling Methocarbamol tablets due to a labeling error. Bottles labeled as containing Methocarbamol 500mg tablets actually contain Methocarbamol 750mg tablets.
The affected product is Methocarbamol 500mg Tablet packaged by Bryant Ranch Prepack in Burbank, California, and distributed nationwide. Three package sizes are involved: #30 count bottles (NDC 7133517952), #60 count bottles (NDC 7133517954), and #90 count bottles (NDC 7133517957). The recalled lot is #163935 with an expiration date of 10/31/2022.
Consumers and healthcare providers should stop using the affected product immediately. Anyone who has taken tablets from these bottles should consult their healthcare provider. Patients should not adjust or stop their medication without medical guidance.
The recalled product
- Product
- Methocarbamol 500mg Tablet, packaged in a) #30 count (NDC 7133517952), b) #60 count (NDC 7133517954), and c) #90 count (NDC 7133517957) bottles, Rx only, Prinston Laboratories, Packaged by Bryant Ranch Prepack Burbank, CA 91504
- Manufacturer
- Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals
- Category
- Drug — Prescription Medication
- Hazard
- labeling-error
- wrong-dose
- overdose-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 163935
- Exp: 10/31/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27